Biological composition, efficacy and primary efficacy endpoint of SARS-CoV-2 vaccines: A special communication.
Sign Up to like & getrecommendations! Published in 2022 at "JPMA. The Journal of the Pakistan Medical Association"
DOI: 10.47391/jpma.4640
Abstract: Severe acute respiratory syndrome coronavirus 2 was first reported in Wuhan, China, in late December 2019 and rapidly spread out globally, affecting 130 million individuals and starting a global pandemic. An efficacious vaccine is considered… read more here.
Keywords: biological composition; efficacy endpoint; efficacy primary; efficacy ... See more keywords